Sign inJoin waitlistJoin the waitlist

CT

Christopher Takimoto

Medical Oncology

Credentials: ·

History

Medical Oncology
Internal Medicine

Research

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
New England Journal of Medicine · 2018 · 972 citations
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab
Journal of Clinical Oncology · 2007 · 969 citations
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Journal of Clinical Oncology · 2001 · 860 citations

Jean Grem
33 papers
ER
Eric Rowinsky
26 papers
AT
Anthony Tolcher
25 papers
CA
Carmen Allegra
22 papers
AP
Amita Patnaik
18 papers
AM
Alain Mita
15 papers
AC
Alice Chen
13 papers
JH
J. Hamilton
12 papers
MM
Monica Mita
11 papers · 1 as a fellow
Dan Mulkerin
9 papers
GS
Garry Schwartz
9 papers
RR
Ramesh Ramanathan
9 papers